- Lobbying
- Lobbying by Columbia Care
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Oscar Ramirez | Special Asst. to the Secretary, Dept. of Labor // Chief of Staff, Rep. Hilda Solis // Leg. Director/Deputy CoS, Rep. Al Green // Leg. Asst./Asst. LD/LD, Rep. Joe Baca Special Asst. to the Secretary, Department of Labor // Chief of Staff, Rep. Hilda Solis (D-CA-32) // Legislative Director/Deputy Chief of Staff, Rep. Al Green (D-TX-09) // Legislative Assistant / Legislative Director, Rep. Joe Baca (D-CA-43) |
Dana Thompson | LD/Chf. Counsel, Rep. Maxine Waters // L. Cnsl/C. Cnsl/Dpty COS/COS, Rep. Sheila Jackson Lee Legislative Director / Chief Counsel, Rep. Maxine Waters (D-CA-43) // Legislative Counsel / Chief Counsel / Deputy Chief of Staff / Chief of Staff, Rep. Sheila Jackson Lee (D-TX-18) |
Sarah Monteith | Rep. Derek Kilmer (D-WA)Rep. Josh Harder (D-CA); Sen. Patty Murray (D-WA) Legislative Aide, Sen. Patty Murray (D-WA) // Legislative Assistant, Rep. Josh Harder (D-CA-10) // Legislative Assistant, Rep. Derek Kilmer (D-WA-06) |
Miya Patel | Leg. Assistant, Rep. Joe Neguse // Leg. Counsel, Rep. John Delaney // Legal Fellow, House Financial Services Comm. Legislative Assistant, Rep. Joe Neguse (D-CO-02) // Legislative Counsel, Rep. John Delaney (D-MD-06) // Legal Fellow, House Financial Services Committee |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Pharmacy
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Pharmacy
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Pharmacy
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Pharmacy
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Pharmacy
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Pharmacy
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medical
Pharmacy
Registration
Issue(s) they said they’d lobby about: Issues related to regulation of medical cannabis.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate